Aaltomaa S - Search Results

1

Expression of activator protein 2 in prostate cancer is related to tumor differentiation and cell proliferation.

Lipponen P, Aaltomaa S, Kellokoski J, Ala-Opas M, Kosma V. Lipponen P, et al. Among authors: aaltomaa s. Eur Urol. 2000 May;37(5):573-8. doi: 10.1159/000020195. Eur Urol. 2000. PMID: 10765096

2

Prediction of outcome after first recurrence of breast cancer.

Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Marin S, Alhava E, Syrjänen K. Aaltomaa S, et al. Eur J Surg. 1992 Jan;158(1):13-8. Eur J Surg. 1992. PMID: 1348633

3

Nuclear morphometry and DNA flow cytometry as prognostic factors in female breast cancer.

Aaltomaa S, Lipponen P, Papinaho S, Klemi P, Kosma VM, Marin S, Eskelinen M, Alhava E, Syrjänen K. Aaltomaa S, et al. Eur J Surg. 1992 Mar;158(3):135-41. Eur J Surg. 1992. PMID: 1356452

4

Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining.

Aaltomaa S, Lipponen P, Syrjänen K. Aaltomaa S, et al. Anticancer Res. 1992 Jul-Aug;12(4):1281-6. Anticancer Res. 1992. PMID: 1380227

5

DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer.

Lipponen P, Papinaho S, Eskelinen M, Klemi PJ, Aaltomaa S, Kosma VM, Marin S, Syrjänen K. Lipponen P, et al. Among authors: aaltomaa s. Anticancer Res. 1992 Sep-Oct;12(5):1533-8. Anticancer Res. 1992. PMID: 1444217

6

Demographic prognostic factors in breast cancer.

Aaltomaa S, Lipponen P, Eskelinen M. Aaltomaa S, et al. Acta Oncol. 1992;31(6):635-40. doi: 10.3109/02841869209083845. Acta Oncol. 1992. PMID: 1466891

7

Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymph-node-positive breast cancer.

Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Marin S, Alhava E, Syrjänen K. Aaltomaa S, et al. Eur Surg Res. 1992;24(3):160-8. doi: 10.1159/000129203. Eur Surg Res. 1992. PMID: 1499604

8

Breast cancer in young women: clinical, histological and morphometric prognostic factors.

Eskelinen M, Lipponen P, Aaltomaa S, Kosma VM, Syrjänen K, Alhava E. Eskelinen M, et al. Among authors: aaltomaa s. Anticancer Res. 1992 Jul-Aug;12(4):1237-42. Anticancer Res. 1992. PMID: 1503415

9

Lymphocyte infiltrates as a prognostic variable in female breast cancer.

Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Marin S, Alhava E, Syrjänen K. Aaltomaa S, et al. Eur J Cancer. 1992;28A(4-5):859-64. doi: 10.1016/0959-8049(92)90134-n. Eur J Cancer. 1992. PMID: 1524909

10

Histological assessment of the prognostic factors in female breast cancer.

Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Mari S, Alhava E, Syrjänen K. Aaltomaa S, et al. Oncology. 1992;49(1):1-8. doi: 10.1159/000227001. Oncology. 1992. PMID: 1542486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results